Risk factors for radiographic progression in psoriatic arthritis: subanalysis of the randomized controlled trial ADEPT.

Risk factors for radiographic progression in psoriatic arthritis: subanalysis of the randomized controlled trial ADEPT.

Item
http://www.wikidata.org/entity/Q34027596
Which Psoriasis Patients Develop Psoriatic Arthritis?Predictors of response to TNF antagonists in patients with ankylosing spondylitis and psoriatic arthritis: systematic review and meta-analysis.Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: an indirect comparison meta-analysis.Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritis.Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future.Effect of tumour necrosis factor blockers on radiographic progression of psoriatic arthritis: a systematic review and meta-analysis of randomised controlled trials.Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis.Predictors for clinical outcome in psoriatic arthritis - what have we learned from cohort studies?Progress in understanding and utilizing TNF-α inhibition for the treatment of psoriatic arthritis.European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update.Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA recommendations.Pattern of bone erosion and bone proliferation in psoriatic arthritis hands: a high-resolution computed tomography and radiography follow-up study during adalimumab therapy.Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: results from the nationwide Danish DANBIO registry.Tumour necrosis factor α blockers are more effective than methotrexate in the inhibition of radiographic joint damage progression among patients with psoriatic arthritis.Classification and Outcome Measures for Psoriatic Arthritis
P2860

Risk factors for radiographic progression in psoriatic arthritis: subanalysis of the randomized controlled trial ADEPT.

Item
http://www.wikidata.org/entity/Q34027596
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Risk factors for radiographic ...... omized controlled trial ADEPT.
@ast
Risk factors for radiographic ...... omized controlled trial ADEPT.
@en
Risk factors for radiographic ...... omized controlled trial ADEPT.
@nl
type
label
Risk factors for radiographic ...... omized controlled trial ADEPT.
@ast
Risk factors for radiographic ...... omized controlled trial ADEPT.
@en
Risk factors for radiographic ...... omized controlled trial ADEPT.
@nl
prefLabel
Risk factors for radiographic ...... omized controlled trial ADEPT.
@ast
Risk factors for radiographic ...... omized controlled trial ADEPT.
@en
Risk factors for radiographic ...... omized controlled trial ADEPT.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698
P932
P356
P1433
P1476
Risk factors for radiographic ...... omized controlled trial ADEPT.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698
P932